134 related articles for article (PubMed ID: 35608967)
1. Penetrance of Parkinson disease LRRK2 G2385R-associated variant in the Chinese population.
Wang P; Cui P; Luo Q; Chen J; Tang H; Zhang L; Chen S; Ma J
Eur J Neurol; 2022 Sep; 29(9):2639-2644. PubMed ID: 35608967
[TBL] [Abstract][Full Text] [Related]
2. A 10-Year Community-Based Study of Leucine-Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease.
Wang P; Pan J; Luo Q; Chen J; Tang H; Chen S; Ma J
Mov Disord; 2022 Aug; 37(8):1767-1772. PubMed ID: 35733392
[TBL] [Abstract][Full Text] [Related]
3. Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease.
Cui SS; Fu R; Du JJ; Lin YQ; Huang P; Gao C; Zhou HY; Chen SD
BMC Neurosci; 2021 Mar; 22(1):22. PubMed ID: 33771108
[TBL] [Abstract][Full Text] [Related]
4. Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants.
Wang C; Cai Y; Zheng Z; Tang BS; Xu Y; Wang T; Ma J; Chen SD; Langston JW; Tanner CM; Chan P;
Parkinsonism Relat Disord; 2012 Sep; 18(8):958-63. PubMed ID: 22658533
[TBL] [Abstract][Full Text] [Related]
5. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.
Gao C; Pang H; Luo XG; Ren Y; Shang H; He ZY
J Neurol; 2013 Nov; 260(11):2884-9. PubMed ID: 24046064
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of PD patients with LRRK2 G2385R and R1628P variants.
Liang D; Shu L; Pan H; Xu Q; Guo J; Yan X; Tang B; Sun Q
Neurosci Lett; 2018 Oct; 685():185-189. PubMed ID: 30121215
[TBL] [Abstract][Full Text] [Related]
8. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
[TBL] [Abstract][Full Text] [Related]
9. Fatigue correlates with LRRK2 G2385R variant in Chinese Parkinson's disease patients.
Fu R; Cui SS; Du JJ; He YC; Gao C; Huang P; Qian YW; Luo XG; Chen SD
Parkinsonism Relat Disord; 2017 Nov; 44():101-105. PubMed ID: 28941828
[TBL] [Abstract][Full Text] [Related]
10. The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies.
Xie CL; Pan JL; Wang WW; Zhang Y; Zhang SF; Gan J; Liu ZG
Neurol Sci; 2014 Oct; 35(10):1495-504. PubMed ID: 25027012
[TBL] [Abstract][Full Text] [Related]
11. Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants.
Yang J; Wang H; Yuan Y; Fan S; Li L; Jiang C; Mao C; Shi C; Xu Y
Ann Clin Transl Neurol; 2021 Mar; 8(3):592-602. PubMed ID: 33527742
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.
San Luciano M; Tanner CM; Meng C; Marras C; Goldman SM; Lang AE; Tolosa E; Schüle B; Langston JW; Brice A; Corvol JC; Goldwurm S; Klein C; Brockman S; Berg D; Brockmann K; Ferreira JJ; Tazir M; Mellick GD; Sue CM; Hasegawa K; Tan EK; Bressman S; Saunders-Pullman R;
Mov Disord; 2020 Oct; 35(10):1755-1764. PubMed ID: 32662532
[TBL] [Abstract][Full Text] [Related]
14. Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.
Marder K; Wang Y; Alcalay RN; Mejia-Santana H; Tang MX; Lee A; Raymond D; Mirelman A; Saunders-Pullman R; Clark L; Ozelius L; Orr-Urtreger A; Giladi N; Bressman S;
Neurology; 2015 Jul; 85(1):89-95. PubMed ID: 26062626
[TBL] [Abstract][Full Text] [Related]
15. Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.
Li DW; Gu Z; Wang C; Ma J; Tang BS; Chen SD; Chan P
J Neural Transm (Vienna); 2015 May; 122(5):661-7. PubMed ID: 25062988
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.
Hulihan MM; Ishihara-Paul L; Kachergus J; Warren L; Amouri R; Elango R; Prinjha RK; Upmanyu R; Kefi M; Zouari M; Sassi SB; Yahmed SB; El Euch-Fayeche G; Matthews PM; Middleton LT; Gibson RA; Hentati F; Farrer MJ
Lancet Neurol; 2008 Jul; 7(7):591-4. PubMed ID: 18539535
[TBL] [Abstract][Full Text] [Related]
17. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.
Marras C; Alcalay RN; Caspell-Garcia C; Coffey C; Chan P; Duda JE; Facheris MF; Fernández-Santiago R; Ruíz-Martínez J; Mestre T; Saunders-Pullman R; Pont-Sunyer C; Tolosa E; Waro B;
Mov Disord; 2016 Aug; 31(8):1192-202. PubMed ID: 27091104
[TBL] [Abstract][Full Text] [Related]
18. The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2.
Rudenko IN; Kaganovich A; Langston RG; Beilina A; Ndukwe K; Kumaran R; Dillman AA; Chia R; Cookson MR
Biochem J; 2017 Apr; 474(9):1547-1558. PubMed ID: 28320779
[TBL] [Abstract][Full Text] [Related]
19. The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.
Rudenko IN; Kaganovich A; Hauser DN; Beylina A; Chia R; Ding J; Maric D; Jaffe H; Cookson MR
Biochem J; 2012 Aug; 446(1):99-111. PubMed ID: 22612223
[TBL] [Abstract][Full Text] [Related]
20. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.
Lee AJ; Wang Y; Alcalay RN; Mejia-Santana H; Saunders-Pullman R; Bressman S; Corvol JC; Brice A; Lesage S; Mangone G; Tolosa E; Pont-Sunyer C; Vilas D; Schüle B; Kausar F; Foroud T; Berg D; Brockmann K; Goldwurm S; Siri C; Asselta R; Ruiz-Martinez J; Mondragón E; Marras C; Ghate T; Giladi N; Mirelman A; Marder K;
Mov Disord; 2017 Oct; 32(10):1432-1438. PubMed ID: 28639421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
